Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Net Cash Flow: 2011-2025

Historic Net Cash Flow for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to $10.9 million.

  • Aytu Biopharma's Net Cash Flow rose 1545.10% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year increase of 8595.83%. This contributed to the annual value of $10.9 million for FY2025, which is 467.44% up from last year.
  • Aytu Biopharma's Net Cash Flow amounted to $10.9 million in FY2025, which was up 467.44% from -$3.0 million recorded in FY2024.
  • Over the past 5 years, Aytu Biopharma's Net Cash Flow peaked at $10.9 million during FY2025, and registered a low of -$30.5 million during FY2022.
  • Over the past 3 years, Aytu Biopharma's median Net Cash Flow value was $3.6 million (recorded in 2023), while the average stood at $3.9 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first slumped by 2,093.54% in 2022, then soared by 467.44% in 2025.
  • Over the past 5 years, Aytu Biopharma's Net Cash Flow (Yearly) stood at $1.5 million in 2021, then slumped by 2,093.54% to -$30.5 million in 2022, then spiked by 111.87% to $3.6 million in 2023, then slumped by 182.18% to -$3.0 million in 2024, then soared by 467.44% to $10.9 million in 2025.